Bladder carcinoma in situ (CIS) is a multifocal, non–muscle-invasive disease with a high risk of progression to muscle-invasive cancer. Current management strategies are often guided by genomic profiling of single tumor samples, which incompletely capture tumor heterogeneity and may contribute to treatment failure. In particular, the multifocal nature of CIS raises uncertainty regarding the uniformity of genomic, immunologic, and microenvironmental features across anatomically distinct sites within the same patient. To address this, we performed spatial transcriptomic profiling of CIS-containing tissue from four anatomically distinct sites within a single individual. Unsupervised clustering with marker-based annotation, integrated with metabolic inference, identified epithelial tumor populations alongside stromal, immune, and smooth muscle compartments. While key cellular states were conserved, their spatial organization and relative abundance varied by site. Metabolic analysis further revealed region-specific microenvironments shaped by local cellular architecture. These findings indicate that both cellular composition and metabolic activity are spatially structured. Collectively, these results demonstrate that CIS exhibits significant intra-patient heterogeneity not captured by single-site profiling. These findings require validation in larger cohorts but support multi-region sampling could help improve risk stratification, biomarker development, and prediction of response to intravesical therapies, with potential implications for more personalized treatment strategies.
Tyler Myers, A. Salmasi, M. Meagher et al.· bioRxiv· 0 citations
Integrating multi-omics data is essential for microbiome research, as microbial communities are shaped by and respond to interdependent processes, including taxonomic composition, metabolite production and utilization, and gene expression. However, accurately capturing ecosystem-wide patterns across these modalities is statistically challenging due to differences in scale, sparsity, and compositionality. While a growing number of multi-omics methods have emerged, they differ in their mathematical objectives and modeling assumptions, which in turn shape how biological patterns are represented and interpreted. This underscores the need for tools that explicitly account for the statistical properties of microbial ecosystems. Here, we present Joint Robust Principal Component Analysis (Joint-RPCA), a method designed with these statistical properties in mind and broadly applicable to multi-omics settings with similar challenges. Built on the OptSpace matrix completion framework, Joint-RPCA assumes an underlying shared low-rank structured component across modalities to identify shared variation and cross-modal associations from matched samples. Within this setting and under these statistical assumptions, Joint-RPCA showed stronger performance than the benchmarked general-purpose methods in phenotype separation and feature association tasks, achieving up to sixfold improvement in classification accuracy and over 100-fold faster runtimes. Applied to real-world datasets, including the Integrative Human Microbiome Project (iHMP), mammalian gut microbiomes, and decomposition studies, Joint-RPCA reveals replicable and interpretable multi-omic patterns, offering a scalable and domain-aware solution for systems-level microbiome analysis. Joint-RPCA is available in both Python ( https://github.com/biocore/gemelli ) and R ( https://bioconductor.org/packages/mia ).
Bianca Cordazzo Vargas, C. Martino, A. Dilmore et al.· Molecular Systems Biology· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
